The Latest Breaking News from FDA

A medical ethics expert says a Texas abortion pill ruling is unprecedented because a federal judge "standing in" for regulators could have far-reaching implications beyond mifepristone.

On Friday, federal Judge Matthew Kacsmaryk handed down a decision further restricting abortion access nationwide by suspending the Food and Drug Administration’s approval of mifepristone, the most common and safe pill used for medication abortion. Another ruling, from a federal judge in Washington state, ordered the F.D.A. to make no…

The drug mifepristone is safe. In fact, what’s unsafe is its absence, as the lack of the crucial abortion-inducing drug will push women to have abortions in more dangerous ways, which is why it’s been FDA-approved for more than 20 years.

Massachusetts, California and Washington pledge to provide medication after a federal judge invalidated 23-year FDA approval

WASHINGTON — The Biden administration asked a federal appeals court to suspend a ruling by a conservative U.S. judge in Texas that would block access nationwide to a key drug used in medication abortions — even as it sought clarity on a conflicting order in Washington state.

Advocates, providers, medical groups and drugmakers wrestle with uncertainty, confusion and frustration

WASHINGTON — The Justice Department and several Democrat-led states took steps Monday to preserve access to a commonly used medication abortion drug after dueling federal court rulings about its availability.

SACRAMENTO, Calif. — Gov. Gavin Newsom announced Monday that California will stockpile an emergency supply of 2 million abortion pills known as misoprostol in response to a federal judge in Texas ruling against the authorization of another medication that has been used to terminate pregnancies for decades.

The abortion pill mifepristone accounts for more than half of all abortions in the US and is considered safe to use.

WASHINGTON — The Biden administration asked a federal appeals court to suspend a ruling by a conservative U.S. judge in Texas blocking access to an abortion pill nationwide at the end of the week.

Pfizer’s Albert Bourla is among the CEOs who signed a letter against suspending mifepristone, citing its impact on the FDA and the biotech industry.